One or two nights a week, I get a call from an unknown number. On the other end is a frightened patient — or more often, a parent — searching desperately for a treatment that might save a life.

Too often, I can’t help. Time and again, tragically, the only difference between a patient receiving a potentially life-saving treatment or not is government bureaucracy. The Food and Drug Administration needs to ensure that the government is keeping pace with the latest scientific developments.

Not long ago, the parents of a 21-year-old woman from Italy called me. She had colon cancer — a diagnosis that was once almost unheard of in someone so young, but is now disturbingly common. Her parents requested an immunotherapy combination that my company is currently developing. After many delays, she f

See Full Page